Xiaofan Neo Zhang - 18 Mar 2026 Form 3 Insider Report for NovaBridge Biosciences (NBP)

Role
Chief Investment Officer
Signature
/s/ Xi-Yong (Sean) Fu as attorney-in-fact
Issuer symbol
NBP
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 21:40:46 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zhang Xiaofan Neo Chief Investment Officer C/O NOVABRIDGE BIOSCIENCES,, 2440 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE /s/ Xi-Yong (Sean) Fu as attorney-in-fact 18 Mar 2026 0002121304

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBP Ordinary Shares 874,000 18 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
F2 Reported securities are represented by 380,000 ADSs.

Remarks:

Exhibit List: Ex. 24.1 - Power of Attorney